MBIO — MindBio Therapeutics Balance Sheet
0.000.00%
- CA$5.40m
- CA$9.74m
Annual balance sheet for MindBio Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 0.48 | 1.35 | 0.334 |
Net Total Receivables | 0.001 | 0.046 | 0.054 |
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 0.481 | 1.7 | 0.673 |
Total Assets | 0.481 | 1.7 | 0.673 |
Payable / Accrued | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 0.957 | 0.994 | 2.93 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Minority Interest | |||
Total Other Liabilities | |||
Total Liabilities | 0.957 | 5.9 | 6.03 |
Common Stock | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | -0.476 | -4.19 | -5.36 |
Total Liabilities & Shareholders' Equity | 0.481 | 1.7 | 0.673 |
Total Common Shares Outstanding |